Amazon and PillPack: Disruptions and Innovations on the Horizon

Amazon and PillPack: Disruptions and Innovations on the Horizon

By BBK Worldwide on Thu, Jul 26, 2018 | 1 min read

There is no doubt that Amazon’s recent acquisition of PillPack – the independent pharmacy and medication distribution system – has major implications not only for the clinical research industry, but the healthcare industry at-large. We asked BBK Worldwide president Matt Kibby to weigh in on Amazon’s foray into the pharmaceutical space. His responses indicate the possibility for major disruptions as well as major innovations, particularly for IVR companies, drug delivery, and virtual clinical trials. Watch Matt Kibby’s response to the PillPack acquisition, and tell us what you think by leaving a comment below.

Topics: Pharma15, Vlog